The National Institutes of Health has granted more than $24 million over the past 20 years to study the effects of the Transcendental Meditation (TM) program and other related programs on cardiovascular disease. The following is a summary of findings of the published research as well as a listing of universities where recent studies have been conducted.
Reduced Blood Pressure. The treatments employed included simple biofeedback, relaxation-assisted biofeedback, progressive muscle relaxation, stress management training, and the Transcendental Meditation program. The results of statistical analysis showed that none of the first 4 treatment approaches demonstrated statistically significant reductions in elevated blood pressure, while the Transcendental Meditation program showed both significant clinical and statistical reductions in blood pressure.
Improved Quality of Life for Congestive Heart Failure Patients. This study examined the effects of conventional health education and the practice of the Transcendental Meditation technique on measures of heart failure severity and quality of life in a randomized controlled trial of twenty-three older African American men and women with congestive heart failure (CHF). The results indicate that the use of the TM technique may be effective in improving the quality of life and functional capacity of heart failure patients.
Enhanced Longevity. This study was a first-of-its-kind, long-term, randomized trial. It evaluated the death rates of 202 men and women, average age 71, who had mildly elevated blood pressure. Subjects in the study participated in the Transcendental Meditation program; behavioral techniques, such as mindfulness or progressive muscle relaxation; or health education. The study tracked subjects for up to 18 years. The study found that the TM program reduced death rates by 23%.
Reduced Atherosclerosis. In the study, 57 adults were randomly assigned into three treatment groups. After one year, the ceratoid intima-media thickness decreased significantly more in the subjects who were randomly assigned to the TM group.
To read more go to National Institute of Health